Trial of Avigan drug not yet final

The Department of Health on Friday corrected its earlier statement that Aug. 10 was the start of the clinical trials in the Philippines of the Japanese anti-viral flu drug Avigan, saying it was not yet final.

The department said legal documents had yet to be finalized, and just hours after it said Aug. 10 was the start of the trials.

“At first we said that we would start on August 10, but we hadn’t finalized the legal documents. So we just want to inform everybody that if everything is final, then we will start,” Health Undersecretary Maria Rosario Vergeire said at a virtual forum.

"But it's going to happen soon.”

Vergeire earlier in the day mentioned Aug. 10 as the start of the clinical trials for Avigan in the Philippines.

Avigan is the brand name of the drug favipiravir. It was developed by what is now known as Fujifilm Toyama Chemical and was approved for use in Japan in 2014.

Topics: Department of Health , clinical trials , anti-viral flu , drug Avigan ,
COMMENT DISCLAIMER: Reader comments posted on this Web site are not in any way endorsed by Manila Standard. Comments are views by readers who exercise their right to free expression and they do not necessarily represent or reflect the position or viewpoint of While reserving this publication’s right to delete comments that are deemed offensive, indecent or inconsistent with Manila Standard editorial standards, Manila Standard may not be held liable for any false information posted by readers in this comments section.
AdvertisementSpeaker GMA